Kiniksa shareholders elect three Class I directors, ratify PwC, approve say-on-pay

Kiniksa Pharmaceuticals International, plc

Sanj K. Patel, Thomas R. Malley, Richard S. Levy elected as Class I directors with 33.3M, 31.5M, 34.4M votes for respectively.
Ratification of PricewaterhouseCoopers as auditor for FY2022 approved: 45.3M for, 33k against, 27k abstained.
Advisory say-on-pay proposal approved: 41.5M for, 333k against, 56.6k abstained; 3.45M broker non-votes.
Annual meeting held June 29, 2022; quorum present with Class A and Class B shares voting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.